ESR1 and neoplasm: Selective estrogen receptor modulators like tamoxifen and aromatase inhibitors such as anastrozole, letrozole, and exemestane, as well as selective estrogen receptor degraders such as fulvestrant play crucial roles in inhibiting hormone-driven tumor growth [14].